F-Prime Capital Partners
VC
INVESTOR TYPE
Active
STATUS
25
PROFESSIONALS
242
INVESTMENTS
114
PORTFOLIO
67
EXITS
Description
F-Prime Capital Partners is a venture capital firm headquartered in Cambridge, Massachusetts. The firm seeks to make investments in firms focused in biopharmaceutical, medtech, healthcare service, enterprise information technology and fintech.
Website
Formerly Known As
Fidelity Biosciences
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1969
Primary Investor Type
Venture Capital
Primary Office
- 1 Main Street
- 13th Floor
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
F-Prime Capital Partners Investments (242)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Checkmate Pharmaceuticals | 12-Dec-2018 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | 000 0000000 |
| 00 0000000000 | 30-Nov-2018 | 00000 00000 | 0000 | Hospitals/Inpatient Services | Generating Revenue | 00000000 000 |
| 00000 | 13-Nov-2018 | 00000 00000 | 0000 | Financial Software | Generating Revenue | 00000 00000 00 |
| 000000 | 09-Oct-2018 | 00000 00000 | 0000 | Information Services (B2C) | Generating Revenue | |
| 00000 000000000000 | 01-Oct-2018 | 00000 00000 | 0000 | Therapeutic Devices | Product Development | 000 0000000 |
| 0000000 0000000000 | 27-Sep-2018 | 00000 00000 | 0000 | Biotechnology | Product Development | 000000 0000 00 |
| 0000 0000000 00000 | 21-Sep-2018 | 00000 00000 | 0000 | Practice Management (Healthcare) | Generating Revenue | 0000 00000 |
| 0000000000 | 10-Sep-2018 | 00000 00000 | 0000 | Other Information Technology | Generating Revenue | 000000 00000000 |
| Sana Therapeutics | 10-Sep-2018 | Seed Round | 000 | Personal Products | Generating Revenue | 0000000 000000 00 |
| Notable | 06-Sep-2018 | Early Stage VC | 000.00 | Medical Records Systems | Generating Revenue | 0000 00000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore F-Prime Capital Partners’s full profile, request a free trial.
F-Prime Capital Partners Exits (67)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Innovent Biologics | 31-Oct-2018 | IPO | 00000 | Completed |
|
| 0000000 0000000000 | 31-Oct-2018 | 000 | 00000 | Completed |
|
| 000 00000000 | 14-Sep-2018 | 000 | 00000 | Completed |
|
| 00000 (00000000) | 26-Apr-2018 | 000000000000000000 | 000.00 | Completed |
|
| 0000000 00000000 | 23-Apr-2018 | 000 | 00000 | Completed |
|
| 000000 00000000000 | 09-Apr-2018 | 000000000000000000 | 00000 | Completed |
|
| 0000000 0000000000 | 31-Mar-2018 | 000000000 00000000 | Completed |
|
|
| 0000 000000000000 | 29-Mar-2018 | 000 | 000.00 | Completed |
|
| Acacia Pharma | 05-Mar-2018 | IPO | 000.00 | Completed |
|
| Tetraphase Pharmaceuticals | 01-Mar-2018 | Secondary Transaction - Open Market | Completed |
|
F-Prime Capital Partners Team (57)
16 Former Team Members
You’re viewing 5 of 57 team members. Get the full list »F-Prime Capital Partners Co-Investors (453)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Eight Roads | 30 | 0 | 00 |
| OrbiMed | 0 | 0 | 0 |
| New Enterprise Associates | 0 | 0 | 0 |
| Venrock | 0 | 0 | 0 |
| Polaris Partners | 0 | 0 |